Journal of the Korean Ophthalmological Society 2007;48(4):599-603.
Published online April 30, 2007.
A Case of Primary Mucinous Adenocarcinoma of the Upper Eyelid.
Hee Chun Seo, Min Ahn, Nam Chun Cho, Dong Ouk Lee
Department of Ophthalmology, Chonbuk National University, College of Medicine, Jeonju, Korea. ahnmin@chonbuk.ac.kr
상안검에 발생한 원발성 점액샘암종 1예
서희춘,안민,조남천,이동욱
Department of Ophthalmology, Chonbuk National University, College of Medicine, Jeonju, Korea
Correspondence:  Hee Chun Seo, M.D.
Abstract
PURPOSE
We report a case of a recurrent, non-tender mass on the right upper eyelid, which was completely excised and histologically diagnosed as mucinous adenocarcinoma from the eccrine gland. METHODS: A 67-year-old man presented with a non-tender subcutaneous mass on the right upper eyelid, which had developed 6 months prior to presentation. A similar eyelid mass had also been removed one year earlier. We surgically removed some skin and the mass and conducted a biopsy. During the operation, the biopsy revealed it to be mucinous adenocarcinomas, and thus it was removed by Mohs' excision technique with a clean margin. RESULTS: A mucinous adenocarcinoma from the eccrine gland was diagnosed by a histologic examination of the removed mass. A whole-body examination was conducted to determine if the lesion was primary or metastatic, and the results indicated it was primary lesion. There was no evidence of other malignant lesions, and a 21-month follow-up is currently being conducted in case of recurrence. CONCLUSIONS: Primary mucinous adenocarcinoma occuring on an eyelids is a very rare malignant tumor. Complete mass removal is well known to be the best treatment. For differential diagnosis, various examinations of the entire body are required in case the lesion had metastasized from the breast, gastrointestinal tract, kidneys, ovaries, lacrimal glands and so on. Periodical postoperative examinations must be thoroughly performed, since the probability of recurrence is about 30%.
Key Words: Eccrine gland;Eyelid;Mucinous adenocarcinoma


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603    Fax: +82-2-2277-5194    E-mail: kos@ijpnc.com                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next